Literature DB >> 23925464

[Hydroxyethyl starch : position statement by the Presidents of the DGAI (German Society of Anaesthesiology and Intensive Care Medicine), the BDA (Professional Association of German Anaesthetists) and the DAAF (German Academy for Further Education in Anaesthesiology)].

C Werner, G Geldner, T Koch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23925464     DOI： 10.1007/s00101-013-2219-1

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


× No keyword cloud information.
  6 in total

1.  Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

Authors:  Anders Perner; Nicolai Haase; Anne B Guttormsen; Jyrki Tenhunen; Gudmundur Klemenzson; Anders Åneman; Kristian R Madsen; Morten H Møller; Jeanie M Elkjær; Lone M Poulsen; Asger Bendtsen; Robert Winding; Morten Steensen; Pawel Berezowicz; Peter Søe-Jensen; Morten Bestle; Kristian Strand; Jørgen Wiis; Jonathan O White; Klaus J Thornberg; Lars Quist; Jonas Nielsen; Lasse H Andersen; Lars B Holst; Katrin Thormar; Anne-Lene Kjældgaard; Maria L Fabritius; Frederik Mondrup; Frank C Pott; Thea P Møller; Per Winkel; Jørn Wetterslev
Journal:  N Engl J Med       Date:  2012-06-27       Impact factor: 91.245

2.  Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

Authors:  F Schortgen; J C Lacherade; F Bruneel; I Cattaneo; F Hemery; F Lemaire; L Brochard
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

3.  Hydroxyethyl starch or saline for fluid resuscitation in intensive care.

Authors:  John A Myburgh; Simon Finfer; Rinaldo Bellomo; Laurent Billot; Alan Cass; David Gattas; Parisa Glass; Jeffrey Lipman; Bette Liu; Colin McArthur; Shay McGuinness; Dorrilyn Rajbhandari; Colman B Taylor; Steven A R Webb
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

4.  [Study protocol of the VISEP study. Response of the SepNet study group].

Authors:  K Reinhart; F M Brunkhorst; C Engel; F Bloos; A Meier-Hellmann; M Ragaller; N Weiler; O Moerer; M Gruendling; M Oppert; S Grond; D Olthoff; U Jaschinski; S John; R Rossaint; T Welte; M Schaefer; P Kern; E Kuhnt; M Kiehntopf; T Deufel; C Hartog; H Gerlach; F Stüber; H-D Volk; M Quintel; M Loeffler
Journal:  Anaesthesist       Date:  2008-07       Impact factor: 1.041

5.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

Authors:  Frank M Brunkhorst; Christoph Engel; Frank Bloos; Andreas Meier-Hellmann; Max Ragaller; Norbert Weiler; Onnen Moerer; Matthias Gruendling; Michael Oppert; Stefan Grond; Derk Olthoff; Ulrich Jaschinski; Stefan John; Rolf Rossaint; Tobias Welte; Martin Schaefer; Peter Kern; Evelyn Kuhnt; Michael Kiehntopf; Christiane Hartog; Charles Natanson; Markus Loeffler; Konrad Reinhart
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

6.  Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study.

Authors:  Bertrand Guidet; Olivier Martinet; Thierry Boulain; Francois Philippart; Jean François Poussel; Julien Maizel; Xavier Forceville; Marc Feissel; Michel Hasselmann; Alexandra Heininger; Hugo Van Aken
Journal:  Crit Care       Date:  2012-05-24       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.